NEW YORK (GenomeWeb News) – The UK lab that is currently serving as an anti-doping testing facility for the 2012 Olympic and Paralympic games will be turned into a research center that will focus on phenomics-based disease studies.

The UK's Department of Health said today that the Olympics lab near London, in Harlow, which was provided by GlaxoSmithKline and is operated by King's College London, will be transformed into a facility that is supported by the Medical Research Council and the National Institute of Health Research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.